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ABSTRACT
PCR was used to investigate the occurrence of the
plasmid-encoded quinolone resistance determi-
nants qnrA and qnrS among diarrhoeagenic
enterobacterial isolates recovered from Hanoi,
Vietnam, during the period March 2001 to April
2002. In total, 162 Escherichia coli isolates, 28
Shigella isolates and three Enterobacter cloacae
isolates were negative for qnrA, while a single
Ent. cloacae isolate harboured a 50-kb qnrS-posit-
ive conjugative plasmid. Cloning and sequencing
identiﬁed a qnrS gene bracketed by open reading
frames identical to those surrounding the qnrS
gene of a Shigella ﬂexneri isolate from Japan,
thereby suggesting a common mechanism of
acquisition.
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Quinolone resistance in Enterobacteriaceae usu-
ally results from mutations in genes coding for
chromosomally-encoded type II topoisomerases,
efﬂux pumps, or porin-related proteins [1]. How-
ever, Martinez-Martinez et al. [2] observed that
quinolone resistance can also be plasmid-medi-
ated. This latter mechanism involves the QnrA
protein, which protects DNA by preventing bind-
ing of quinolones to gyrase and topoisomerase IV
[3–5]. QnrA was ﬁrst reported in a Klebsiella
pneumoniae isolate from the USA, but has been
found subsequently worldwide [2,6–11]. QnrA
increases the MICs of ﬂuoroquinolones by up to
32-fold [6], and is thought to have originated in
Shewanella algae [12]. Two other plasmid-mediated
quinolone resistance determinants have now been
reported: qnrS in a single Shigella ﬂexneri isolate
from Japan, and qnrB in Citrobacter koseri, Escheri-
chia coli, Enterobacter cloacae and K. pneumoniae
isolates from the USA and India [13] (44th
International Conference on Antimicrobial Agents
and Chemotherapy, abstract C2-1898a). QnrB and
QnrS share 41% and 60% amino-acid identity,
respectively, with QnrA [6].
The aim of the present study was to investigate
the occurrence of the qnrA and qnrS genes (the
sequence of the qnrB gene was not available) in a
collection of diarrhoeagenic enterobacterial iso-
lates (community-acquired pathogens) from Viet-
nam. In total, 162 diarrhoeagenic Esch. coli isolates
[14], including 86 enteroaggregative, 12 enteroin-
vasive, 50 enteropathogenic and 14 enterotoxigenic
isolates, and 28 Shigella spp., including one Shigella
boydii, seven Shig. ﬂexneri and 20 Shigella sonnei,
were investigated initially. Resistance percentages
to nalidixic acid and ciproﬂoxacin were 19.1% and
3.7%, respectively, for Esch. coli, and 7.1% and
3.6%, respectively, for Shigella spp. [14]. During the
course of isolation from faeces, three Ent. cloacae
isolates were also obtained; these isolates, inclu-
ding strain 287 (see below), were susceptible to
nalidixic acid and ﬂuoroquinolones according to
CLSI criteria (MIC resistance breakpoints of >4 and
‡32 mg ⁄L for ciproﬂoxacin and nalidixic acid,
respectively [15]) (Table 1).
Genomic DNA was extracted as described
previously [16]. PCRs were performed using
standard techniques [17] and speciﬁc primers
for the qnrA and qnrS genes. Primers QnrA-A
(5¢-GGGTATGGATATTATTGATAAAG) and
QnrA-B (5¢-CTAATCCGGCAGCACTATTA) [11]
ampliﬁed the qnrA gene, and primers QnrS-A2
(5¢-AGTGATCTCACCTTCACCGC) and QnrS-B2
(5¢-CAGGCTGCAATTTTGATACC) ampliﬁed the
qnrS gene (this study). The qnrA- and qnrS-
positive control strains were Esch coli LO [9] and
Esch. coli (pBCH2.6) (a gift from M. Hata) [13],
respectively.
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All Esch. coli and Shigella isolates were negative
for the qnrS and qnrA genes, but a single
Ent. cloacae isolate (strain 287) was positive for
the qnrS gene. This isolate was resistant to most
penicillins, cephalothin and cefoxitin, but was
susceptible to expanded-spectrum cephalosporins
(data not shown). Like the qnrS-positive Shig.
ﬂexneri isolate 8 from Japan [13], but in contrast to
most qnrA-positive enterobacterial isolates [6],
strain 287 displayed a narrow-spectrum b-lacta-
mase resistance proﬁle, and remained in the
susceptibility range for quinolones and ﬂuoroqu-
inolones according to CLSI criteria [15] (Table 1).
Thus, the presence of the qnrS gene may remain
hidden, if based solely on the results of antibiotic
susceptibility testing.
PCR assays using primers to detect b-lactamase
genes (blaTEM, blaSHV, blaCTX-M, blaVEB) [9,15]
identiﬁed a blaTEM-1 b-lactamase gene in Ent. cloa-
cae 287, and this strain was found to contain three
plasmids of c. 70, 50 and 40 kb following com-
parison with reference plasmids of known sizes
[16]. Transfer of the qnrS gene from Ent. cloacae
287 to azide-resistant Esch. coli J53 occurred fol-
lowing conjugation experiments [2,9] and selec-
tion on agar containing azide 100 mg ⁄L and
amoxycillin 100 mg ⁄L. A 50-kb self-conjugative
plasmid, p287 that carried the qnrS gene, but not
the blaTEM-1 gene, was identiﬁed. This plasmid
encoded resistance to narrow-spectrum penicil-
lins that was inhibited by clavulanic acid, as well
as resistance to chloramphenicol, nalidixic acid
and ﬂumequine, but not to ﬂuoroquinolones
(Table 1). MICs of quinolones and ﬂuoroquinolo-
nes for Esch. coli J53 (p287) were equal or slightly
higher than those for qnrA-positive Esch. coli J53
(Table 1).
Cloning experiments were used to identify the
entire sequence of the qnrS gene and the sur-
rounding DNA sequences, as described previ-
ously [9]. Genomic DNA of Ent. cloacae strain 287
was digested with HindIII and ligated into the
HindIII site of plasmid pBK-CMV [16]. One of the
recombinant plasmids obtained (p287HN2), with
an insert of 3498 bp, was retained for further
sequencing. A putative promoter was identiﬁed
upstream of the qnrS gene, with a )10 box located
Table 1. MICs (mg ⁄L) of quinolones and ﬂuoroquinolones
for Enterobacter cloacae 287, the Escherichia coli J53 (p287)
transconjugant, and the Esch. coli J53 reference strain. MICs
obtained for the QnrA-positive Esch. coli J53 (pQR1)
transconjugant [9] are included for comparison
Antibiotic
Ent. cloacae
287
(qnrS)
Esch. coli
J53
(p287)
(qnrS)
Esch. coli
J53
(pQR1)
(qnrA)
Esch. coli
J53
Nalidixic acid 16 32 32 4
Flumequine 8 32 16 2
Oxolinic acid 4 16 8 1
Sparﬂoxacin 2 2 1 0.01
Moxiﬂoxacin 1 1 1 0.03
Oﬂoxacin 1 2 1 0.12
Norﬂoxacin 2 2 1 0.06
Ciproﬂoxacin 0.5 0.5 0.25 0.01
Fig. 1. Schematic map of the insert sequence of recombinant plasmid p287HN2 compared with that of plasmid pAH0376
from Shigella ﬂexneri 8 isolated in Japan [13]. The HindIII restriction sites are indicated. The internal site located in pAH0376
is absent in p287HN2. Genes are indicated by horizontal arrows, with orf indicating a gene encoding a protein similar to
that identiﬁed in IS2. The whole blaTEM-1-carrying Tn3-like transposon is indicated, with its tnpR resolvase and tnpA
transposase genes. Putative )35 and )10 promoter sequences for the qnrS gene of plasmid p287HN2 are shown (ﬁgure not
to scale).
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51 bp upstream of the qnrS start codon, separated
by 16 bp from a )35 box (Fig. 1). This promoter
was probably the natural promoter for the qnrS
gene. This feature differed from those associated
with the qnrA gene, for which the promoter
sequences form part of a CR1 element, itself
forming part of a sul1-type integron [9] (Fig. 1).
Upstream of the promoter sequence of the qnrS
gene, an open reading frame resembling that of
the IS2 element was identiﬁed. This element was
identical to that found upstream of the qnrS gene
in plasmid pAH0376 from Shig. ﬂexneri 8 [12]
(Fig. 1). In addition, the same putative DNA
resolvase gene was present downstream of both
qnrS genes [12] (Fig. 1). A Tn3-like element
carrying blaTEM-1 was identiﬁed further upstream
of the qnrS gene in plasmid pAH0376 from
Shig. ﬂexneri strain 8, but this element was absent
from p287HN2, indicating that this transposon
may not always be involved in mobilisation of
the qnrS gene. Compared with the DNA sequence
of pAH0376, the insert of p287HN2 lacked a
HindIII restriction site and, curiously, differed
totally at the left extremity of that restriction site
(Fig. 1).
This study is the ﬁrst systematic survey for
the qnrS determinant. Only a low frequency of
qnrA ⁄ qnrS plasmid-mediated quinolone resist-
ance determinants was detected among commu-
nity-acquired diarrhoeagenic pathogens in
Vietnam. This is the second report to show that
qnrS is not embedded in a sul1-type integron,
which is in contrast to qnrA-like genes [6]. Thus,
the mechanisms for acquisition of qnrS genes may
differ from those of qnrA genes. The situation may
be similar to that observed for the emerging
community-acquired blaCTX-M genes, mostly in
Esch. coli, that are mobilised either by insertion
sequences or by sul1-type integrons [18].
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